Aperio Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $20.2M | Sell |
1,111,580
-132,202
| -11% | -$2.41M | 0.06% | 308 |
|
2020
Q3 | $22.2M | Buy |
1,243,782
+213,340
| +21% | +$3.81M | 0.07% | 249 |
|
2020
Q2 | $18.5M | Buy |
1,030,442
+279,898
| +37% | +$5.02M | 0.07% | 279 |
|
2020
Q1 | $11.4M | Sell |
750,544
-264,687
| -26% | -$4.02M | 0.05% | 371 |
|
2019
Q4 | $20M | Buy |
1,015,231
+187,958
| +23% | +$3.71M | 0.07% | 293 |
|
2019
Q3 | $14.2M | Buy |
827,273
+229,309
| +38% | +$3.94M | 0.06% | 370 |
|
2019
Q2 | $10.6M | Sell |
597,964
-284,447
| -32% | -$5.03M | 0.04% | 457 |
|
2019
Q1 | $18M | Buy |
882,411
+643,224
| +269% | +$13.1M | 0.08% | 287 |
|
2018
Q4 | $4.02M | Buy |
+239,187
| New | +$4.02M | 0.02% | 723 |
|
2014
Q2 | – | Sell |
-290,284
| Closed | -$6.9M | – | 1755 |
|
2014
Q1 | $6.9M | Buy |
+290,284
| New | +$6.9M | 0.1% | 264 |
|
2013
Q4 | – | Sell |
-235,055
| Closed | -$5.55M | – | 255 |
|
2013
Q3 | $5.55M | Buy |
235,055
+30,386
| +15% | +$718K | 0.11% | 236 |
|
2013
Q2 | $4.62M | Buy |
+204,669
| New | +$4.62M | 0.11% | 228 |
|